This inventor holds 149 USPTO granted patents and 53 published patent applications and 35 EPO patents, primarily in Thrombectomy Devices (CPC class A61B2017-22038). Top assignees: Stryker Corporation, Covidien LP, Target Therapeutics, Inc.. Active years: 1997-2026.
Inventors with similar research interests:
Location History:
- La Grange, NC (US) (2022)
- Pleasanton, CA (US) (1997 - 2024)
- Sunnyvale, CA (US) (2016 - 2024)
Company Filing History:
43 out of 2,501 
14 out of 8,136 
14 out of 211 
Years Active: 1997-2026
Areas of Expertise:
Title: Michael P Wallace: A Pioneering Inventor in Vascular Technologies
Introduction:
In the realm of medical innovations, inventors like Michael P Wallace have played a pivotal role in advancing life-saving technologies. Hailing from Pleasanton, California, Wallace has established himself as a prominent figure in the development of vaso-occlusive devices. With a remarkable portfolio of patents and a career spent at esteemed companies, his contributions have significantly impacted the field of vascular interventions.
Latest Patents:
With an impressive total of 120 patents to his name, Wallace has consistently demonstrated his expertise in the realm of vaso-occlusive technologies. His latest patents showcase his proficiency in designing cutting-edge solutions. Notable among them are his inventions related to vaso-occlusive devices, specifically those targeting the treatment of aneurysms.
One of these patents describes a vaso-occlusion system comprising a delivery catheter, a pusher member, and an expandable braid formed from a group of elongate braid filaments. This system allows for effective occlusion of an aneurysm, aiding in its treatment and prevention of further complications.
Career Highlights:
Throughout his career, Michael P Wallace has made significant professional strides, contributing to the growth and success of various companies. He has prominently worked with Stryker Corporation, a global leader in medical technology, and Target Therapeutics, Inc.
While the precise details of Wallace's achievements within these companies are not available, his impressive patent count serves as a testament to his dedication and expertise within the medical device industry. His contributions to the field of vaso-occlusive devices have undoubtedly helped improve patient outcomes and advance medical science.
Collaborations:
Innovation often thrives on collaborations, and Michael P Wallace has been no stranger to working with other talented individuals. Some of his notable colleagues include E Skott Greenhalgh and Robert Garabedian. Together, they have likely shared knowledge and collaborated on projects, contributing to the development of advanced medical technologies in the field of vascular interventions.
Conclusion:
Michael P Wallace's ingenuity and expertise have made him a remarkable figure in the realm of medical innovations and patents. With an extraordinary number of patents to his credit, he has demonstrated an unwavering commitment to improving vascular interventions, particularly in the treatment and occlusion of aneurysms. As a key contributor within companies such as Stryker Corporation and Target Therapeutics, Inc., Wallace has proven himself to be an invaluable asset to the advancement of medical science.